clinical trial · NCT05774080
An Observational Study of Patients With Chronic Gastrointestinal Disease
Target PharmaSolutions, Inc.·—·active not recruiting·n = 500,000
Gastrointestinal DiseasesObservational
brief summary
TARGET-GASTRO is an observational research study to conduct a comprehensive review of outcomes for patients with the chronic gastrointestinal (GI) diseases: eosinophilic gastrointestinal disease (EGID), ulcerative colitis (UC) or Crohn's disease (CD).
started
Aug 1, 2023
primary completion
Dec 1, 2037
completion
Dec 1, 2037
last updated
Jan 29, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol